thyroid cancer – Generic Meds Mart

Soranib 200 mg Sorafenib – 30, 120 Tablets

gmm_wpuser — Fri, 21 Nov 2025 02:32:50 +0000

Buy Soranib 200 mg Sorafenib Tablets Online

Soranib 200 mg Tablets – 1 pack / 120 tabs, 1 pack / 30 tabs

At a Glance

Generic Name: Sorafenib

Brand Name: Soranib

Strength & Pack Options: 200 mg tablets; 1 pack / 120 tabs and 1 pack / 30 tabs

Dosage Form: Film-coated oral tablets

Therapeutic Class: Multikinase inhibitor, targeted anticancer therapy

Main Indications: Advanced hepatocellular carcinoma, advanced renal cell carcinoma and differentiated thyroid carcinoma as indicated

Use in Therapy: Systemic oral treatment for unresectable or metastatic disease as per specialist guidance

Prescription Status: Prescription-only oncology medicine

Supplied By: Licensed manufacturers and authorised distributors

Storage: Store below 25 °C in a dry, protected place away from moisture and light

Product Description

Soranib 200 mg contains sorafenib, a targeted multikinase inhibitor used in the systemic treatment of certain advanced solid tumours.
Many liver, kidney and thyroid cancers rely on signalling pathways that control cell growth and blood vessel formation.
By blocking specific kinases within these pathways, Soranib sorafenib tablets help slow tumour progression in patients with unresectable or metastatic disease.

The Soranib 200 mg tablet is widely recognised as a generic sorafenib 200 mg option.
At Generic Meds Mart, Soranib is offered as a variable product with two convenient pack sizes:
1 pack / 120 tablets and 1 pack / 30 tablets. This flexibility allows your oncologist and pharmacist to match the pack size with treatment duration,
follow-up intervals and budget in USD.

In practice, sorafenib is used for unresectable or metastatic hepatocellular carcinoma (HCC), advanced renal cell carcinoma (RCC)
and certain forms of differentiated thyroid carcinoma that are refractory to radioactive iodine.
Soranib 200 mg sorafenib tablets provide the same active ingredient and strength as originator sorafenib while offering an accessible generic alternative for long courses of therapy.

The 120-tablet pack is often suitable for roughly one and a half to two months of treatment, depending on the prescribed daily dose, whereas the
30-tablet pack can be used for shorter cycles, treatment initiation, dose adjustments or smaller, more frequent purchases.
Regardless of pack size, Soranib 200 mg must always be used exactly as directed by an experienced oncologist.
Generic Meds Mart does not initiate or modify cancer treatment; our role is to provide reliable access to generic sorafenib tablets that match your written treatment plan.

Key Uses

Soranib 200 mg (sorafenib) tablets are generally used for the following indications under specialist supervision:

Unresectable or metastatic hepatocellular carcinoma (advanced liver cancer)
Advanced renal cell carcinoma (kidney cancer) according to current guidelines
Progressive, differentiated thyroid carcinoma that is refractory to radioactive iodine

Your oncology team will decide whether Soranib 200 mg is appropriate and how it fits within your overall systemic therapy plan.

How Sorafenib Works in Chemotherapy

Sorafenib is an oral targeted anticancer agent and a multikinase inhibitor.
It is frequently grouped with modern systemic chemotherapy and targeted therapies for liver, kidney and thyroid cancer, although its mechanism differs from classic cytotoxic drugs.

Soranib sorafenib tablets inhibit several intracellular and cell-surface kinases, including RAF kinases and receptors in the
VEGFR and PDGFR pathways. These kinases promote tumour cell proliferation and tumour angiogenesis (new blood vessel formation).
By blocking these targets, Soranib 200 mg exerts both antiproliferative and anti-angiogenic effects, which can slow tumour growth and reduce blood supply to the tumour.

This dual mechanism may help stabilise disease and prolong progression-free survival in selected patients with advanced HCC, RCC or thyroid cancer.
Because these pathways are also present in normal tissues, sorafenib therapy can cause systemic side effects, making careful monitoring by an experienced oncologist essential.

Dosage & Administration

Soranib 200 mg sorafenib tablets must always be taken exactly as prescribed by your oncology team.
The total daily dose, treatment schedule and any dose modifications are based on your diagnosis, body weight, organ function, other medicines and side-effect profile.

A commonly used starting dose is 400 mg twice daily (two 200 mg Soranib tablets in the morning and two in the evening), unless your doctor advises otherwise.
Take tablets by mouth with water, with or without food, following your doctor’s specific instructions about meals.
Swallow Soranib tablets whole; do not crush, split or chew them unless a pharmacist gives specific handling advice.
Take doses at approximately the same times each day to maintain consistent sorafenib exposure.
If you miss a dose, follow the written guidance from your treatment centre; do not double your next dose unless your doctor specifically instructs you to.

Your oncologist may adjust or temporarily interrupt Soranib 200 mg therapy if you experience significant side effects or abnormal laboratory results.

Precautions

Before starting Soranib 200 mg, tell your healthcare team about your full medical history and all medicines, supplements and herbal products you use. Key precautions include:

Pre-existing liver disease, cirrhosis, viral hepatitis or abnormal liver function tests
History of cardiovascular disease, coronary artery disease, arrhythmias, heart failure or uncontrolled hypertension
Recent major surgery or planned operations, due to possible effects on wound healing
History of bleeding disorders, gastrointestinal ulcers, varices or previous significant haemorrhage
Use of anticoagulants or antiplatelet medicines that may increase bleeding risk
Concomitant use of strong inducers or inhibitors of drug-metabolising enzymes that may alter sorafenib levels
Pregnancy or breastfeeding; sorafenib tablets are not recommended and may harm an unborn baby

Men and women of reproductive potential are usually advised to use reliable contraception during and for a period after Soranib sorafenib treatment, as directed by their oncologist.

Sorafenib Side Effects

Common side effects

Many patients experience side effects when they first start Soranib 200 mg. Common adverse reactions may include:

Hand–foot skin reaction (redness, pain, thickening or blistering on palms and soles)
Skin rash, dryness or peeling
Diarrhea or loose stools
Fatigue, low energy or asthenia
Nausea, occasional vomiting or reduced appetite
Weight loss over time
Hair thinning or alopecia
Mild to moderate increases in blood pressure

These effects are often manageable with supportive measures, topical treatments, dose reductions or temporary interruptions as decided by your oncology team.

Serious side effects

Less common but serious side effects of sorafenib require urgent medical attention. These may include:

Severe hypertension or hypertensive crisis
Chest pain, shortness of breath or signs of heart ischaemia
Significant bleeding, such as black or bloody stools, coughing or vomiting blood
Signs of serious liver injury: yellowing of the skin or eyes, dark urine, pale stools, intense upper abdominal pain
Gastrointestinal perforation or severe, persistent abdominal pain
Severe skin reactions, blistering or mucosal involvement
Sudden severe headache, visual changes or neurological symptoms suggestive of a vascular event

If you experience any of these serious symptoms while taking Soranib 200 mg sorafenib tablets, seek emergency medical care immediately and contact your oncology team without delay.

Storage

Store Soranib 200 mg tablets at room temperature, preferably below 25 °C.
Keep tablets in their original blisters and outer carton to protect them from moisture and light.
Keep all anticancer medicines out of the sight and reach of children and pets.
Do not use after the expiry date printed on the packaging.

Ask your pharmacist how to safely dispose of unused or expired Soranib sorafenib tablets; do not throw them into household waste or wastewater.

Why Buy from Generic Meds Mart

Generic Meds Mart is dedicated to providing safe access to key oncology medicines such as
Soranib 200 mg sorafenib tablets at transparent prices in USD.
We source only from licensed manufacturers and authorised distributors that comply with recognised GMP standards and maintain a reliable export record.

When you buy Soranib 200 mg online from Generic Meds Mart, you benefit from:

Flexible pack sizes (30 and 120 tablets) that reflect real clinical usage
Discreet, plain outer packaging for international delivery
Tracked shipping options to many destinations
Clear, structured product information to support discussions with your oncology team
Customer support to help with ordering, payment and delivery questions

Order Now

Soranib 200 mg sorafenib tablets are prescription-only targeted anticancer medicines and must be used strictly under specialist supervision.
Before you order Soranib online, ensure your oncologist has confirmed sorafenib as part of your treatment plan and specified the daily dose and intended duration.

Select the appropriate pack size – Soranib 200 mg 1 pack / 120 tabs or 1 pack / 30 tabs – add it to your cart and complete the secure checkout on Generic Meds Mart.
Your order will be processed, packed discreetly and shipped with tracking where available. Treatment decisions and dose adjustments must always remain with your healthcare team.

FAQ about Soranib (Sorafenib)

Q1: Do I need a prescription to buy Soranib 200 mg?

Yes. Soranib 200 mg sorafenib tablets are prescription-only targeted anticancer medicines. You must have a valid prescription or written treatment plan from your oncologist before ordering.

Q2: What cancers is Soranib 200 mg used to treat?

Soranib 200 mg is usually prescribed for unresectable or metastatic hepatocellular carcinoma, advanced renal cell carcinoma and certain forms of differentiated thyroid carcinoma that are suitable for sorafenib therapy. Your oncologist will confirm whether Soranib is appropriate in your case.

Q3: How do I choose between the 30-tablet and 120-tablet packs?

The choice of pack size should follow your treatment plan. The 120-tablet pack often suits longer continuous courses, while the 30-tablet pack can be used for shorter cycles, treatment initiation or dose adjustments. Always follow the quantity and schedule defined by your oncology team.

Q4: Can I adjust the dose of Soranib 200 mg myself if I get side effects?

No. Never change the dose or stop Soranib on your own. If you develop side effects such as severe diarrhea, hand–foot skin reaction, high blood pressure or marked fatigue, contact your oncology team promptly. They may adjust the dose or interrupt treatment if needed.

Q5: Is there anything special I should avoid while taking Soranib 200 mg?

Your doctor may advise you to avoid certain medicines that interact with sorafenib, and to limit activities that increase bleeding risk if you are prone to bleeding. You should also avoid starting new prescription drugs, over-the-counter medicines or herbal supplements without checking with your oncology team first.

Sorafenat 200 mg Sorafenib – 30, 60, 120 tablets

gmm_wpuser — Fri, 21 Nov 2025 02:18:30 +0000

Buy Sorafenat Sorafenib – 30, 60, 120 Tablets Online

Sorafenat 200 mg Tablets – 1 pack / 30, 60, 120 tabs

At a Glance

Generic Name: Sorafenib

Brand Name: Sorafenat

Strength & Pack Options: 200 mg film-coated tablets; 1 pack / 30, 60 and 120 tabs

Dosage Form: Oral film-coated tablets

Therapeutic Class: Multikinase inhibitor, targeted anticancer therapy

Main Indications: Advanced hepatocellular carcinoma, advanced renal cell carcinoma and differentiated thyroid carcinoma as indicated

Use in Therapy: Systemic oral treatment for unresectable or metastatic disease as per specialist guidance

Prescription Status: Prescription-only oncology medicine

Supplied By: Licensed manufacturers and authorised distributors

Storage: Store below 25 °C in a dry, protected place away from moisture and light

Product Description

Sorafenat 200 mg contains sorafenib, a targeted multikinase inhibitor used in the systemic treatment of certain advanced solid tumours.
Many liver, kidney and thyroid cancers depend on kinase signalling and tumour blood vessel formation to grow and spread.
By blocking specific kinases within these pathways, Sorafenat sorafenib tablets help slow tumour progression in patients with unresectable or metastatic disease.

As a generic sorafenib 200 mg product, Sorafenat 200 mg provides the same active ingredient and strength as the originator brand while often being more accessible in USD.
At Generic Meds Mart, Sorafenat is available as a variable product with three pack sizes: 1 pack / 30 tablets, 1 pack / 60 tablets and 1 pack / 120 tablets.
This flexibility allows your oncology team to match the quantity of Sorafenat sorafenib tablets to your treatment cycle, review interval and budget.

In clinical practice, sorafenib is used for unresectable or metastatic hepatocellular carcinoma (HCC), advanced renal cell carcinoma (RCC)
and certain forms of differentiated thyroid carcinoma that no longer respond adequately to radioactive iodine.
Sorafenat 200 mg sorafenib tablets offer a generic option in these settings when prescribed by an experienced oncologist.

The 30-tablet pack is often chosen for treatment initiation, dose adjustments or shorter monitored cycles.
The 60-tablet pack covers several weeks of therapy at common doses, and the 120-tablet pack is convenient when your dose is stable and you prefer fewer repeat orders.
Regardless of pack size, Sorafenat 200 mg must always be taken exactly as described in your written treatment plan.
Generic Meds Mart does not initiate or modify therapy; our role is to provide reliable access to generic sorafenib tablets and clear, structured information.

Key Uses

Sorafenat 200 mg (sorafenib) tablets are generally used for the following indications under specialist supervision:

Unresectable or metastatic hepatocellular carcinoma (advanced liver cancer)
Advanced renal cell carcinoma (kidney cancer) when systemic multikinase inhibitor therapy is indicated
Progressive, differentiated thyroid carcinoma that is refractory to radioactive iodine

Your oncology team will determine whether Sorafenat 200 mg is appropriate for you and how it fits into your overall systemic treatment strategy.

How Sorafenib Works in Chemotherapy

Sorafenib is an oral targeted anticancer medicine from the class of multikinase inhibitors.
It is often grouped with modern systemic chemotherapy and targeted therapies for liver, kidney and thyroid cancer, though its mechanism differs from classic cytotoxic drugs.

Sorafenat sorafenib tablets inhibit several intracellular and cell-surface kinases, including RAF kinases and receptors in the
VEGFR and PDGFR pathways. These kinases promote tumour cell proliferation and tumour angiogenesis (formation of new blood vessels).
By blocking these targets, Sorafenat 200 mg exerts both antiproliferative and anti-angiogenic effects, helping to slow tumour growth and reduce tumour blood supply.

This dual action may help stabilise disease and prolong progression-free survival in selected patients with advanced HCC, RCC or differentiated thyroid carcinoma.
Because these pathways are also present in normal tissues, sorafenib therapy can cause systemic side effects, so close monitoring by an experienced oncologist is essential.

Dosage & Administration

Sorafenat 200 mg sorafenib tablets must always be taken exactly as prescribed by your oncology team.
The total daily dose, treatment schedule and any changes or interruptions are defined by your doctor based on your diagnosis, organ function, concomitant medicines and tolerance.

A frequently used starting dose is 800 mg of sorafenib per day (two 200 mg Sorafenat tablets twice daily), unless your doctor advises otherwise.
Take Sorafenat tablets by mouth with water, following your doctor’s instructions on whether to take them with or without food.
Swallow tablets whole; do not break, crush or chew Sorafenat 200 mg unless your pharmacist provides specific handling instructions.
Take doses at approximately the same times each day to maintain consistent sorafenib exposure.
If you miss a dose, follow the written instructions from your treatment centre; do not double your next dose unless your doctor specifically instructs you to do so.

Your oncologist may reduce the dose or temporarily interrupt Sorafenat 200 mg therapy if significant side effects or abnormal test results occur.

Precautions

Before starting Sorafenat 200 mg, tell your healthcare team about your full medical history and all medicines, supplements and herbal products you are taking. Key precautions include:

Pre-existing liver disease, cirrhosis, viral hepatitis or abnormal liver function tests
History of cardiovascular disease, coronary artery disease, arrhythmias, heart failure or uncontrolled hypertension
Recent major surgery or planned operations, due to potential effects on wound healing
History of bleeding disorders, gastrointestinal ulcers, varices or significant prior haemorrhage
Use of anticoagulants or antiplatelet medicines that may increase bleeding risk
Use of strong inducers or inhibitors of drug-metabolising enzymes that may alter sorafenib levels
Pregnancy or breastfeeding; sorafenib tablets are not recommended and may harm an unborn baby

Men and women of reproductive potential are usually advised to use effective contraception during and for a period after Sorafenat sorafenib treatment, as directed by their oncologist.

Sorafenib Side Effects

Common side effects

Many patients experience side effects when starting Sorafenat 200 mg. Common adverse reactions include:

Hand–foot skin reaction (redness, pain, thickening or blistering on palms and soles)
Skin rash, dryness, itching or peeling
Diarrhea or loose stools
Fatigue, low energy or asthenia
Nausea, occasional vomiting or reduced appetite
Weight loss over time
Hair thinning or alopecia
Mild to moderate increases in blood pressure

These side effects are often manageable with supportive care, topical treatments, dose adjustments or temporary interruptions, as decided by your oncology team.

Serious side effects

Less common but serious side effects of sorafenib require urgent medical attention. These may include:

Severe or uncontrolled hypertension or hypertensive crisis
Chest pain, shortness of breath or signs of cardiac ischaemia
Significant bleeding, such as black or bloody stools, vomiting blood or coughing up blood
Signs of serious liver injury: yellowing of the skin or eyes, dark urine, pale stools, intense upper abdominal pain
Gastrointestinal perforation or severe, persistent abdominal pain
Severe skin reactions, blistering or mucosal involvement
Sudden severe headache, visual changes or neurological symptoms suggestive of a vascular event

If you experience any of these serious symptoms while taking Sorafenat 200 mg sorafenib tablets, seek emergency medical care immediately and contact your oncology team.

Storage

Store Sorafenat 200 mg tablets at room temperature, preferably below 25 °C.
Keep tablets in their original blisters and outer carton to protect them from moisture and light.
Keep all anticancer medicines out of the sight and reach of children and pets.
Do not use the product after the expiry date printed on the packaging.

Ask your pharmacist how to safely dispose of unused or expired Sorafenat sorafenib tablets; do not throw them into household waste or wastewater.

Why Buy from Generic Meds Mart

Generic Meds Mart is dedicated to providing safe access to key oncology medicines such as
Sorafenat 200 mg sorafenib tablets at transparent prices in USD.
We source only from licensed manufacturers and authorised distributors that comply with recognised GMP standards and maintain a reliable export record.

When you buy Sorafenat 200 mg online from Generic Meds Mart, you benefit from:

Flexible pack sizes (30, 60 and 120 tablets) that reflect real clinical usage
Discreet, plain outer packaging for international delivery
Tracked shipping options to many destinations
Clear, structured product information to support discussions with your oncology team
Customer support to help with ordering, payment and delivery questions

Order Now

Sorafenat 200 mg sorafenib tablets are prescription-only targeted anticancer medicines and must be used strictly under specialist supervision.
Before you order Sorafenat online, ensure your oncologist has confirmed sorafenib as part of your treatment plan and specified the daily dose and intended duration.

Select the appropriate pack size – Sorafenat 200 mg 1 pack / 30 tabs, 1 pack / 60 tabs or 1 pack / 120 tabs – add it to your cart and complete the secure checkout on Generic Meds Mart.
Your order will be processed, packed discreetly and shipped with tracking where available. All treatment decisions and dose adjustments must remain with your healthcare team.

FAQ about Sorafenat (Sorafenib)

Q1: Do I need a prescription to order Sorafenat 200 mg?

Yes. Sorafenat 200 mg sorafenib tablets are prescription-only targeted anticancer medicines. You must have a valid prescription or written treatment plan from your oncologist before ordering.

Q2: Which cancers is Sorafenat 200 mg used to treat?

Sorafenat 200 mg is generally used for unresectable or metastatic hepatocellular carcinoma, advanced renal cell carcinoma and certain forms of differentiated thyroid carcinoma that are suitable for sorafenib therapy. Your oncology team will confirm whether it is appropriate in your case.

Q3: How should I choose between the 30, 60 and 120 tablet packs?

The choice of pack size should follow your treatment plan. The 30-tablet pack is often used for starting therapy or shorter cycles, the 60-tablet pack for several weeks of treatment and the 120-tablet pack for longer continuous courses. Always follow the pack size and quantity recommended by your oncologist.

Q4: Can I change the dose of Sorafenat 200 mg myself if I experience side effects?

No. Dose changes and treatment interruptions must only be made by your oncology team. If you develop side effects such as significant diarrhea, hand–foot skin reaction, high blood pressure or severe fatigue, contact your doctor promptly for advice rather than altering the dose yourself.

Q5: Are there medicines or supplements I should avoid while taking Sorafenat?

Some medicines, including certain anticoagulants, antiplatelet agents and strong inducers or inhibitors of liver enzymes, can interact with sorafenib. Herbal supplements and over-the-counter products may also pose risks. Always inform your oncology team about everything you are taking and avoid starting new medicines or supplements without their approval.